Cidara Therapeutics Announces Reverse Stock Split
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...
Stay updated with breaking news from Veronica Eames. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...
22.04.2024 - SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) - Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and ...
AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- Araris Biotech AG ("Araris" or "the Company"), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the company will